[1]
2008. Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy. Farmeconomia. Health Economics and Therapeutic Pathways. 9, 3 (Sep. 2008), 125–135. DOI:https://doi.org/10.7175/fe.v9i3.225.